Position in GSK
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$21,716,872
-$60,826 QoQ
Shares Held
414,286
+5.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#71
of 1,033 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Foster Victor Wealth Advisors, LLC holds $146,000,046 across 9 Drug Manufacturers - General names. GSK ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
93,625 | $23,559,795 | |
| 2 | AMGN |
Amgen Inc
|
64,695 | $23,427,353 | |
| 3 | GSK |
GSK plc
This page
|
414,286 | $21,716,872 | |
| 4 | JNJ |
Johnson & Johnson
|
85,335 | $21,672,529 | |
| 5 | PFE |
Pfizer Inc
|
819,225 | $19,726,938 | |
| 6 | LLY |
ELI LILLY & Co
|
15,754 | $18,895,821 | |
| 7 | MRK |
Merck & Co., Inc.
|
122,130 | $15,693,705 | |
| 8 | AZN |
Astrazeneca PLC
|
3,899 | $739,328 |
All Filings in GSK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,716,872 | 414,286 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $21,777,698 | 394,595 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $19,184,693 | 391,205 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $16,636,971 | 385,472 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $13,965,849 | 363,694 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $13,648,528 | 352,311 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $11,913,433 | 352,260 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $11,156,846 | 272,917 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $10,005,072 | 259,872 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $9,279,211 | 216,450 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $5,552,255 | 149,818 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $5,220,000 | 144,000 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $4,988,388 | 139,966 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $4,710,009 | 132,378 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $4,427,850 | 126,006 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,724,101 | 126,541 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $5,012,771 | 117,411 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $4,914,330 | 115,026 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $4,310,448 | 99,656 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $3,044,392 | 81,235 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,689,124 | 68,854 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,752,687 | 50,070 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $947,091 | 26,240 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $520,977 | 14,112 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $251,843 | 6,295 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||